Exercise Tolerance: Clinical Trials

22 trials for Exercise Tolerance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 5 unknown, 2 recruiting, 1 active not recruiting. 12 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 8, Recruiting 2, Unknown 2
Phase 42Completed 1, Unknown 1
Phase 21Completed 1
Phase 31Completed 1

Follow Exercise Tolerance: new trials by email Literature Review of Exercise Tolerance trials Research Report on Exercise Tolerance

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of External Upper Limb Loading on Gait and Trunk Muscle Activity in Cardiac Rehabilitation Patients
External Upper Limb Loading During Treadmill Walking - Cardiovascular Diseases, Cardiac Rehabilitation
Active not recruitingPomeranian University in Slupsk602026-05-152026-10-13
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
NMN and TMG (Euexia), Nicotinamide Mononucleotide (NMN), Placebo - Aging, Frailty
Not applicableRecruitingScott Silveira402026-02-212026-10-07
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
Exercise-based rehabilitation program - Venous Thromboembolism (VTE), Exercise Therapy
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern1602025-12-172026-06-12
Asymmetric High-Flow Nasal Cannula During Pulmonary Rehabilitation in COPD
Asymmetric High-Flow Nasal Cannula (A-HFNC), Conventional Pulmonary Rehabilitation Program - Pulmonary Disease, Chronic Obstructive (COPD), Dyspnea
Not applicableCompletedUniversidad de Santiago de Chile302025-05-022026-04-01
M4C Nutraceutical Intervention Human Health Effects Pilot
M4C - General Health and Wellness, Energy and Vitality
Not applicableUnknownConcordia University Wisconsin202024-06-172024-06-26
Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
Portable cardiac monitor "CardioQvark", Cardiorespiratory stress test, Analysis of exhaled air using the Compact PTR-MS proton mass spectrometer - COVID-19, Endothelial Function
UnknownI.M. Sechenov First Moscow State Medical University1002022-06-022024-03-20
Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.
Intermittent hypoxic-hyperoxic training, Intermittent hypoxic-hyperoxic training/control - COVID-19, Chronic Heart Failure
Not applicableCompletedI.M. Sechenov First Moscow State Medical University432021-12-102025-07-11
Reference Values for the Six-minute Pegboard and Ring Test in Healthy Adults in Turkey
Exercise Tolerance
CompletedUlaş Ar1322021-11-042023-08-24
Effects of High-Flow Nasal Cannula on Exercise Outcomes in Lung Transplant Candidates: A Pilot Study
Performance Tests, Functional Tests - Pulmonary Diseases, Oxygen Therapy
Not applicableCompletedHospital Israelita Albert Einstein102021-06-022024-10-01
Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors
Face-to-face rehabilitation, Telerehabilitation - Covid19, Exercise Tolerance
Not applicableCompletedUniversidade Federal de Pernambuco262021-03-282021-10-05
Validity of Aortic Pulse Wave Velocity in Predicting the 6- Minute Walking Test Before Major Non-cardiac Surgery
Aortic pulse wave velocity measurement, 6 minutes walking test - Perioperative/Postoperative Complications, Surgery
UnknownGrupo Español de Rehabilitación Multimodal1252019-05-012019-03-07
Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status
Hyperthermic Fitness Treatment (HFT), Placebo Hyperthermic Fitness Treatment, Physical Examination - Hypoxia, Altitude, Exercise Tolerance
Not applicableCompletedI.M. Sechenov First Moscow State Medical University672019-01-142020-11-17
The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure
Neprilysin, Enalapril - Heart Failure, Exercise Tolerance
Phase 4CompletedUniversity of Sao Paulo General Hospital522017-06-142020-10-22
Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients
cystic fibrosis - Cystic Fibrosis, Muscle Strength
Not applicableCompletedCagtay Maden632016-05-012023-10-18
Age Related Changes in Cardiac Physiology as a Predictor of Exercise Tolerance
Echo stress test - Aging, Exercise Tolerance
CompletedTel-Aviv Sourasky Medical Center2502016-03-012018-02-15
Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients
Exercise training program with and without FB - Pulmonary Disease, Chronic Obstructive, Breathing Exercises
Not applicableCompletedUniversity of Cadiz162016-01-152019-05-31
Does Treating Hookworm Improve Productivity of Small Subsistence Farmers
albendazole, placebo - Hookworm Stool Burden, Anemia
Not applicableUnknownSalmon, Margaret, M.D.3002014-03-012014-04-02
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Exercise Tolerance, Dyspnea
CompletedMayo Clinic1082011-08-012014-01-09
Markers of Endothelial Function and Exercise CapaciTy in Patients With Left Ventricular Assist Devices (EFECT LVAD)
Endothelial Cells, Exercise Tolerance
CompletedUniversity of Minnesota202010-10-012016-08-05
Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease
Aquatic walking exercise program group 1, Aquatic walking exercise program group 2, Land-based walking exercise group - Peripheral Artery Disease, Vascular Function
Not applicableCompletedPusan National University1472010-05-092020-11-03

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

COVID-19 (3)  ·  Dyspnea (3)  ·  Heart Failure (3)  ·  Lung Diseases (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Altitude Sickness (1)  ·  Ancylostomiasis (1)  ·  Anemia (1)  ·  Aneurysm (1)  ·  Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Conduct Disorder (1)  ·  Cystic Fibrosis (1)  ·  Depression (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (11)  ·  Respiratory Tract Diseases (10)  ·  Lung Diseases (7)  ·  Pathologic Processes (7)  ·  Cardiovascular Diseases (6)  ·  Signs and Symptoms (6)  ·  Vascular Diseases (5)  ·  Heart Diseases (4)  ·  Infections (4)  ·  Respiration Disorders (4)  ·  Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Disease Attributes (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)

Interventions

Albendazole (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Ascorbic Acid (1)  ·  Betaine (1)  ·  Electrocardiography (1)  ·  Enalapril (1)  ·  Neprilysin (1)  ·  Nicotinamide Mononucleotide (1)  ·  Psychological Tests (1)  ·  Restraint, Physical (1)  ·  Standing Position (1)  ·  Telerehabilitation (1)  ·  oligonol (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

I.M. Sechenov First Moscow State Medical University (3)  ·  Cagtay Maden (1)  ·  Concordia University Wisconsin (1)  ·  Federico II University (1)  ·  Grupo Español de Rehabilitación Multimodal (1)  ·  Hospital Israelita Albert Einstein (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Mayo Clinic (1)  ·  Pomeranian University in Slupsk (1)  ·  Pusan National University (1)  ·  Salmon, Margaret, M.D. (1)  ·  Scott Silveira (1)  ·  Seoul National University Hospital (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  Ulaş Ar (1)

Countries

Brazil (3)  ·  Russia (3)  ·  United States (3)  ·  Turkey (Türkiye) (2)  ·  Chile (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Republic of the Congo (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Agnieszka Grochulska, PhD, MSc PT (1)  ·  Ane Abad Motos (1)  ·  Antonio P Barretto, PhD (1)  ·  Barry Borlaug, MD (1)  ·  Christian Salmon, DrSc (1)  ·  Ebru Calik Kutukcu, Assoc.Prof. (1)  ·  Ehud Chorin, MD (1)  ·  Elaine Cristina Pereira (1)  ·  Manuel A GAlvez, MSc (1)

Results publications

PMID 11069801, PMID 25342738, PMID 25697852, PMID 25857307, PMID 27238811, PMID 27730178, PMID 27822031, PMID 28039229, PMID 29957229, PMID 31513270, PMID 31771997, PMID 33992607

NIH funding

2025 (1)